158 related articles for article (PubMed ID: 16200076)
1. Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis.
Olfa KZ; José L; Salma D; Amine B; Najet SA; Nicolas A; Maxime L; Raoudha Z; Kamel M; Jacques M; Jean-Marc S; Mohamed el A; Naziha M
Lab Invest; 2005 Dec; 85(12):1507-16. PubMed ID: 16200076
[TBL] [Abstract][Full Text] [Related]
2. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo.
Marcinkiewicz C; Weinreb PH; Calvete JJ; Kisiel DG; Mousa SA; Tuszynski GP; Lobb RR
Cancer Res; 2003 May; 63(9):2020-3. PubMed ID: 12727812
[TBL] [Abstract][Full Text] [Related]
3. Structural determinants of the selectivity of KTS-disintegrins for the alpha1beta1 integrin.
Kisiel DG; Calvete JJ; Katzhendler J; Fertala A; Lazarovici P; Marcinkiewicz C
FEBS Lett; 2004 Nov; 577(3):478-82. PubMed ID: 15556632
[TBL] [Abstract][Full Text] [Related]
4. Structural and dynamical properties of KTS-disintegrins: A comparison between Obtustatin and Lebestatin.
Daidone I; Aschi M; Patamia M; Bozzi A; Petruzzelli R
Biopolymers; 2013 Jan; 99(1):47-54. PubMed ID: 23097229
[TBL] [Abstract][Full Text] [Related]
5. Targeting α1 inserted domain (I) of α1β1 integrin by Lebetin 2 from M. lebetina transmediterranea venom decreased tumorigenesis and angiogenesis.
Morjen M; Othman H; Abdelkafi-Koubaa Z; Messadi E; Jebali J; El Ayeb M; Abid NS; Luis J; Marrakchi N
Int J Biol Macromol; 2018 Oct; 117():790-799. PubMed ID: 29870815
[TBL] [Abstract][Full Text] [Related]
6. Amino acid sequence and homology modeling of obtustatin, a novel non-RGD-containing short disintegrin isolated from the venom of Vipera lebetina obtusa.
Moreno-Murciano MP; Monleón D; Calvete JJ; Celda B; Marcinkiewicz C
Protein Sci; 2003 Feb; 12(2):366-71. PubMed ID: 12538900
[TBL] [Abstract][Full Text] [Related]
7. Leberagin-C, A disintegrin-like/cysteine-rich protein from Macrovipera lebetina transmediterranea venom, inhibits alphavbeta3 integrin-mediated cell adhesion.
Limam I; Bazaa A; Srairi-Abid N; Taboubi S; Jebali J; Zouari-Kessentini R; Kallech-Ziri O; Mejdoub H; Hammami A; El Ayeb M; Luis J; Marrakchi N
Matrix Biol; 2010 Mar; 29(2):117-26. PubMed ID: 19808093
[TBL] [Abstract][Full Text] [Related]
8. CC5 and CC8, two homologous disintegrins from Cerastes cerastes venom, inhibit in vitro and ex vivo angiogenesis.
Ben-Mabrouk H; Zouari-Kessentini R; Montassar F; Koubaa ZA; Messaadi E; Guillonneau X; ElAyeb M; Srairi-Abid N; Luis J; Micheau O; Marrakchi N
Int J Biol Macromol; 2016 May; 86():670-80. PubMed ID: 26853827
[TBL] [Abstract][Full Text] [Related]
9. Isolation of an Anti-Tumour Disintegrin: Dabmaurin-1, a Peptide Lebein-1-Like, from
Chalier F; Mugnier L; Tarbe M; Aboudou S; Villard C; Kovacic H; Gigmes D; Mansuelle P; de Pomyers H; Luis J; Mabrouk K
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32033352
[TBL] [Abstract][Full Text] [Related]
10. KTS and RTS-disintegrins: anti-angiogenic viper venom peptides specifically targeting the alpha 1 beta 1 integrin.
Calvete JJ; Marcinkiewicz C; Sanz L
Curr Pharm Des; 2007; 13(28):2853-9. PubMed ID: 17979730
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements of KTS-disintegrins for inhibition of alpha(1)beta(1) integrin.
Brown MC; Eble JA; Calvete JJ; Marcinkiewicz C
Biochem J; 2009 Jan; 417(1):95-101. PubMed ID: 18774946
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.
Bolás G; de Rezende FF; Lorente C; Sanz L; Eble JA; Calvete JJ
Toxicon; 2014 Mar; 79():45-54. PubMed ID: 24418176
[TBL] [Abstract][Full Text] [Related]
13. PIVL, a new serine protease inhibitor from Macrovipera lebetina transmediterranea venom, impairs motility of human glioblastoma cells.
Morjen M; Kallech-Ziri O; Bazaa A; Othman H; Mabrouk K; Zouari-Kessentini R; Sanz L; Calvete JJ; Srairi-Abid N; El Ayeb M; Luis J; Marrakchi N
Matrix Biol; 2013 Jan; 32(1):52-62. PubMed ID: 23262217
[TBL] [Abstract][Full Text] [Related]
14. PIVL, a snake venom Kunitz-type serine protease inhibitor, inhibits in vitro and in vivo angiogenesis.
Morjen M; Honoré S; Bazaa A; Abdelkafi-Koubaa Z; Ellafi A; Mabrouk K; Kovacic H; El Ayeb M; Marrakchi N; Luis J
Microvasc Res; 2014 Sep; 95():149-56. PubMed ID: 25173589
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
[TBL] [Abstract][Full Text] [Related]
16. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
17. A horsefly saliva antigen 5-like protein containing RTS motif is an angiogenesis inhibitor.
Ma D; Gao L; An S; Song Y; Wu J; Xu X; Lai R
Toxicon; 2010 Jan; 55(1):45-51. PubMed ID: 19635491
[TBL] [Abstract][Full Text] [Related]
18. Effect of VP12 and viperistatin on inhibition of collagen-receptor-dependent melanoma metastasis.
Staniszewska I; Walsh EM; Rothman VL; Gaathon A; Tuszynski GP; Calvete JJ; Lazarovici P; Marcinkiewicz C
Cancer Biol Ther; 2009 Aug; 8(15):1507-16. PubMed ID: 19502781
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a monomeric disintegrin, ocellatusin, present in the venom of the Nigerian carpet viper, Echis ocellatus.
Smith JB; Theakston RD; Coelho AL; Barja-Fidalgo C; Calvete JJ; Marcinkiewicz C
FEBS Lett; 2002 Feb; 512(1-3):111-5. PubMed ID: 11852062
[TBL] [Abstract][Full Text] [Related]
20. The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model.
Ghazaryan N; Movsisyan N; Macedo JC; Vaz S; Ayvazyan N; Pardo L; Logarinho E
Invest New Drugs; 2019 Oct; 37(5):1044-1051. PubMed ID: 30680583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
